Previous 10 | Next 10 |
Hyperfine ( NASDAQ: HYPR ) has named medical device industry veteran Maria Sainz as President and CEO of Hyperfine, effective Oct. 24, 2022. Scott Huennekens, who currently serves as interim President and CEO, will stay on as Executive Chairperson of the Board. HYPR ...
GUILFORD, Conn., Oct. 06, 2022 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), (“Hyperfine” or “the Company”), the groundbreaking medical device company that created Swoop®, the world's first FDA-cleared portable MRI system™, today announced that ...
SAN JOSE, Calif., Sept. 07, 2022 (GLOBE NEWSWIRE) -- BrightInsight, Inc., provider of the leading global platform for biopharma and medtech regulated digital health solutions, announced today the appointment of Tamara Elias, M.D., Senior Vice President at Nuance, and Scott Huennek...
GUILFORD, Conn., Aug. 24, 2022 (GLOBE NEWSWIRE) -- Hyperfine (Nasdaq: HYPR), the creator of Swoop®, the world's first FDA-cleared portable MRI system™, today announced that management will present at two upcoming conferences: Scott Huennekens, Interim President and Chief...
Wells Fargo has downgraded Hyperfine ( NASDAQ: HYPR ) to equal weight from overweight following disappointing Q2 2022 results Wednesday that included lowering guidance . The firm also cut its price target to $2.40 from $8 (~29% upside based on Wednesday's close). T...
Gainers: T2 Biosystems ( TTOO ) +73% . Veru ( VERU ) +38% . Ginkgo Bioworks ( DNA ) +21% . Inotiv ( NOTV ) +20% . Accuray ( ARAY ) +17% . Losers: Athenex ( ATNX ) -46% . Invitae ( NVTA ) -43% . Cer...
Athenex ( ATNX ) -41% on pricing $30M in stock and warrants offering . Invitae ( NVTA ) -25% . Hyperfine ( HYPR ) -17% on Q2 earnings release . Sonos ( SONO ) -17% on Q3 earnings release . Six Flags Entertainment ( SIX ) ...
Hyperfine, Inc. (HYPR) Q2 2022 Earnings Conference Call August 10, 2022, 16:30 PM ET Company Participants Marissa Bych - Gilmartin Group LLC Scott Huennekens - Interim President and Chief Executive Officer Alok Gupta - Chief Financial Officer Conference Cal...
Hyperfine press release ( NASDAQ: HYPR ): Q2 GAAP EPS of -$0.33 misses by $0.06 . Revenue of $1.53M (+337.1% Y/Y) misses by $0.47M . For further details see: Hyperfine GAAP EPS of -$0.33 misses by $0.06, revenue of $1.53M misses by $0.47M
GUILFORD, Conn., Aug. 10, 2022 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the creator of Swoop®, the world's first FDA-cleared portable MRI system™, today reported financial results for the quarter ended June 30, 2022. Management will host a corresponding conference cal...
News, Short Squeeze, Breakout and More Instantly...
The total number of Hyperfine AI-powered marketing authorizations places the company in a leading position on recently published FDA list. Hyperfine (Nasdaq: HYPR), the groundbreaking medical device company that has redefined brain imaging with the world’s first FDA-cleared porta...
The publication includes a subset of data from the ACTION PMR stroke study and provides early evidence that the Swoop ® system is a promising tool for enabling critical stroke treatment choices in urgent care settings. Hyperfine (Nasdaq: HYPR), the groundbreaking health technol...
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced that it will report financial results for the second ...